About Debiopharm Group
Debiopharm Group is a biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug.
Explore similar firms in the BiotechnologyEmail Format
{first_name}.{last_name}@debiopharm.com — 100.0%
sarah.smith@debiopharm.com
Key Employees
Contact details of 12 Debiopharm Group executives
Sophie Genecand
Raymond Zaugg
Alexandra Le Coz Sanchez
Other Employees
Contact details of 6 Debiopharm Group other employees
Patrick Garrouste
- 
                    
Work email
p***************e@debiopharm.com
 
Valerie Blasco
- 
                    
Work email
v************o@debiopharm.com
 
Claire Laprun
- 
                    
Work email
c***********n@debiopharm.com
 
U003edawn Bonine
- 
                    
Work email
u**************e@debiopharm.com
 
David Cameron
- 
                    
Work email
d***********n@debiopharm.com
 
General Emails
General company emails, e.g. customer support lines
communication@debiopharm.com
Unclassified inbox
mwagner@debiopharm.com
Unclassified inbox
mmurone@debiopharm.com
Unclassified inbox
mbarbier@debiopharm.com
Unclassified inbox
Similar Companies like Debiopharm Group
                  
                  HQ: North Chicago, Illinois, United States
AbbVie is a pharmaceutical company that discovers, develops,...
HQ: North Chicago, Illinois, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals,
Legal Name: AbbVie Inc.
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 22, 2024
Founded Date: 2013
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NYSE:ABBV
Operating Status: Active
                  
                  HQ: Minneapolis, Minnesota, United States
Medtronic develops healthcare technology solutions for vario...
HQ: Minneapolis, Minnesota, United States
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Medical Devices Hospitals & Clinics
Legal Name: Medtronic, plc.
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 27, 2024
Founded Date: 1949
Number of Exits: 28
Company Type: For Profit
Stock Symbol: NYSE:MDT
Operating Status: Active
                  
                  HQ: New York, New York, United States
Pfizer is a biopharmaceutical company that provides affordab...
HQ: New York, New York, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals,
Legal Name: Pfizer Inc.
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Sep 3, 2024
Venture Stage: Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Seed, Venture
Founded Date: 1849
Number of Exits: 19
Company Type: For Profit
Stock Symbol: NYSE:PFE
Operating Status: Active
Investor Type: Corporate Venture Capital, Venture Capital
Company Info
Last updated: 14/07/2025
+41213210111
Lausanne, Vaud, Switzerland
Debiopharm Group General Information
Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.
                